CRT 2023
Power Break Symposium: Eluvia DES in Femoropopliteal Disease: A First Look at 5-Year Outcomes from the IMPERIAL RCT (Non-CME) - Sponsored by Boston Scientific Corporation
William A. Gray, MD, FSCAI
System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States
Disclosure(s): Alucent: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing), Contracted Research (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing), Contracted Research (Ongoing); efemoral: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Contracted Research (Ongoing); phillips: Consultant (Ongoing), Contracted Research (Ongoing); shockwave: Consultant (Ongoing), Contracted Research (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)
Mohammad M. Ansari, MD
Assistant Professor/ Cath Lab Director
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
No relationships to disclose
Anahita Dua, MD MS MBA FACS
Associate Professor of Surgery
Harvard Medical School
Boston, Massachusetts, United States
Disclosure(s): Boston Scientific: Advisory Committee/Board Member (Ongoing); Gore: Consultant (Ongoing)